Publications

    2024

    339.
    Bojmar L., Zambirinis C. P., Hernandez J. M. et al. (2024) Nature Medicine. 30, 8, p. 2170-2180  Abstract [All authors]
    338.
    Lim L. Q. J., Adler L., Hajaj E. et al. (2024) Nature metabolism. 6, 7, p. 1294-1309  Abstract [All authors]
    337.
    Lü Y. Q., Cho T., Mukherjee S. et al. (2024) Molecular Systems Biology. 20, 6, p. 719-740  Abstract [All authors]
    336.
    Böpple K., Oren Y., Henry W. S. et al. (2024) Cell Death and Disease. 15, 290.  Abstract [All authors]
    335.
    Abbas R., Hartmann O., Asiss D. T. et al. (2024) Apoptosis. 29, 7-8, p. 1145-1160  Abstract [All authors]
    334.
    Oren M. & Prives C. (2024) Cell. 187, 7, p. 1569-1573  Abstract

    2023

    333.
    Hassin O., Sernik M., Seligman A. et al. (2023) Proceedings of the National Academy of Sciences of the United States of America. 120, 52, e231146012.  Abstract [All authors]
    332.
    Gershoni A., Hassin O., Nataraj N. B. et al. (2023) Molecular Oncology. 17, 12, p. 2675-2693  Abstract [All authors]
    331.
    Michael D., Feldmesser E., Gonen C. et al. (2023) FEBS Letters. 597, 9, p. 1233-1245  Abstract [All authors]
    330.
    Vitale I., Pietrocola F., Guilbaud E. et al. (2023) Cell Death and Differentiation. 30, 5, p. 1097-1154  Abstract [All authors]
    329.
    Venghateri J. B., Dassa B., Morgenstern D., Shreberk-Shaked M., Oren M. & Geiger B. (2023) Cell Death and Disease. 14, 4, 290.  Abstract
    328.
    Hassin O. & Oren M. (2023) Nature reviews. Drug discovery. 22, 2, p. 127-144  Abstract
    327.
    Aylon Y., Furth N., Mallel G. et al. (2023) Nature Communications. 14, 1, 133.  Abstract [All authors]

    2022

    326.
    Hassin O., Nataraj N. B., Shreberk-Shaked M. et al. (2022) Nature Communications. 13, 1, 2800.  Abstract [All authors]
    325.
    Aylon Y., Furth N., Mallel G. et al. (2022) Nature Communications. 13, 1, 7199.  Abstract [All authors]
    324.
    Tuval A., Brilon Y., Azogy H. et al. (2022) Haematologica. 107, 11, p. 2548-2561  Abstract [All authors]
    323.
    Noronha A., Belugali Nataraj N., Sang Lee J. et al. (2022) Cancer Discovery. 12, 11, p. 2666-2683  Abstract [All authors]
    322.
    Mukherjee S., Maddalena M., Lü Y. et al. (2022) Proceedings of the National Academy of Sciences. 119, 17, e211964411.  Abstract [All authors]

    2021

    321.
    Maddalena M., Mallel G., Nataraj N. B. et al. (2021) Proceedings of the National Academy of Sciences. 118, 23, e202563111.  Abstract [All authors]
    320.
    Ghosh S., Nataraj N. B., Noronha A. et al. (2021) Cell Reports. 35, 8, 109181.  Abstract [All authors]

    2020

    319.
    Shreberk-Shaked M., Dassa B., Sinha S. et al. (2020) Cancer Research. 80, 19, p. 4145-4157  Abstract [All authors]
    318.
    Benor G., Fuks G., Chin S. et al. (2020) Molecular Oncology. 14, 8, p. 1640-1652  Abstract [All authors]
    317.
    Hoshino A., Kim H. S., Bojmar L. et al. (2020) Cell. 182, 4, p. 1044-1061.e18  Abstract [All authors]
    316.
    Kadosh E., Snir-Alkalay I., Venkatachalam A. et al. (2020) Nature. 586, 7827, p. 133-138  Abstract [All authors]

    2019

    315.
    Oren M. (2019) Journal of Molecular Cell Biology. 11, 7, p. 539-543  Abstract
    314.
    Shreberk-Shaked M. & Oren M. (2019) Molecular Oncology. 13, 6, p. 1335-1341  Abstract
    313.
    Hooda J., Novak M., Salomon M. P. et al. (2019) Cancer Research. 79, 4, p. 760-772  Abstract [All authors]

    2018

    312.
    Furth N., Pateras I. S., Rotkopf R. et al. (2018) Life science alliance. 1, 5, 201800171.  Abstract [All authors]
    311.
    Minzel W., Venkatachalam A., Fink A. et al. (2018) Cell. 175, 1, p. 171-185  Abstract [All authors]
    310.
    Kotler E., Segal E. & Oren M. (2018) Molecular & cellular oncology. 5, 6, 1511207.  Abstract
    309.
    Kotler E., Shani O., Goldfeld G. et al. (2018) Molecular Cell. 71, 1, p. 178-190  Abstract [All authors]
    308.
    Jethwa A., Slabicki M., Huellein J. et al. (2018) Blood. 131, 25, p. 2789-2802  Abstract [All authors]
    307.
    Arandkar S., Furth N., Elisha Y. et al. (2018) Proceedings Of The National Academy Of Sciences Of The United States Of America-Biological Sciences. 115, 25, p. 6410-6415  Abstract [All authors]
    306.
    Ghannam-Shahbari D., Jacob E., Kakun R. R. et al. (2018) Oncogene. 37, 17, p. 2213-2224  Abstract [All authors]
    305.
    Solomon H., Dinowitz N., Pateras I. S. et al. (2018) Oncogene. 37, 12, p. 1669-1684  Abstract [All authors]
    304.
    Galluzzi L., Vitale I., Aaronson S. A. et al. (2018) Cell Death and Differentiation. 25, 3, p. 486-541  Abstract [All authors]
    303.
    Furth N., Aylon Y. & Oren M. (2018) Cell Death and Differentiation. 25, p. 81-92  Abstract

    2017

    302.
    Enuka Y., Feldman M. E., Chowdhury A. et al. (2017) Nucleic Acids Research. 45, 22, p. 1268112699  Abstract [All authors]
    301.
    Spolverini A., Fuchs G., Bublik D. R. & Oren M. (2017) Oncogene. 36, 42, p. 5819-5828  Abstract
    300.
    Aylon Y. & Oren M. (2017) Cancer Cell. 32, 4, p. 397-399  Abstract
    299.
    Tovy A., Spiro A., McCarthy R. et al. (2017) GENES & DEVELOPMENT. 31, 10, p. 959-972  Abstract
    [All authors]
    298.
    Tarcic O., Granit R. Z., Pateras I. S. et al. (2017) Cell Death and Differentiation. 24, 4, p. 694-704  Abstract [All authors]
    297.
    Bublik D. R., Bursac S., Sheffer M. et al. (2017) Proceedings of the National Academy of Sciences of the United States of America. 114, 4, p. E496-E505  Abstract [All authors]
    296.
    Isaac R., Goldstein I., Furth N. et al. (2017) Cell Death and Differentiation. 24, 1, p. 132-143  Abstract [All authors]

    2016

    295.
    Simerzin A., Zorde-Khvalevsky E., Rivkin M. et al. (2016) Hepatology. 64, 5, p. 1623-1636  Abstract [All authors]
    294.
    Aylon Y. & Oren M. (2016) Cell cycle (Georgetown, Tex.). 15, 17, p. 2248-2255  Abstract
    293.
    Yaeger R., Shah M. A., Miller V. A. et al. (2016) Gastroenterology. 151, 2, p. 278-287.e6  Abstract [All authors]
    292.
    Oren M. & Kotler E. (2016) Nature Cell Biology. 18, 8, p. 833-835  Abstract
    291.
    Stock K., Estrada M. F., Vidic S. et al. (2016) Scientific Reports. 6, 28951.  Abstract [All authors]
    290.
    Aylon Y. & Oren M. (2016) Cold Spring Harbor perspectives in medicine. 6, 10, a026328.  Abstract
    289.
    Orsolic I., Jurada D., Pullen N., Oren M., Eliopoulos A. G. & Volarevic S. (2016) Seminars in Cancer Biology. 37-38, p. 36-50  Abstract
    288.
    Barbier M., Jaensch S., Cornelissen F. et al. (2016) PLoS ONE. 11, 6, e0156942.  Abstract [All authors]
    287.
    Aylon Y., Gershoni A., Rotkopf R. et al. (2016) GENES & DEVELOPMENT. 30, 7, p. 786-797  Abstract [All authors]
    286.
    Tal P., Eizenberger S., Cohen E., Goldfinger N., Pietrokovski S., Oren M. & Rotter V. (2016) Oncotarget. 7, 11, p. 11817-11837  Abstract
    285.
    Tarcic O., Pateras I. S., Cooks T. et al. (2016) Cell Reports. 14, 6, p. 1462-1476  Abstract [All authors]
    284.
    Hoffman Y., Bublik D. R., Ugalde A. P., Elkon R., Biniashvili T., Agami R., Oren M. & Pilpel Y. (2016) PLoS Genetics. 12, 2, e1005879.  Abstract
    283.
    Oren M., Tal P. & Rotter V. (2016) AGING-US. 8, 6, p. 1159-1160  Abstract

    2015

    282.
    Golomb L., Sagiv A., Pateras I., Maly A., Krizhanovsky V., Gorgoulis V., Oren M. & Ben-Yehuda A. (2015) Cell Death and Differentiation. 22, 11, p. 1764-1774  Abstract
    281.
    Blume C. J., Hotz-Wagenblatt A., Hüllein J. et al. (2015) Leukemia. 29, 10, p. 2015-2023  Abstract [All authors]
    280.
    Harel S., Ben-Moshe N., Aylon Y. et al. (2015) Cell Death and Differentiation. 22, p. 1328-1340  Abstract [All authors]
    279.
    Oren M., Damalas A., Gottlieb T. et al. (2015) Biochemical Pharmacology. 96, 4, p. 369 12280.  Abstract [All authors]
    278.
    Pribluda A., Elyada E., Wiener Z. et al. (2015) Cancer Cell. 27, 6, p. 877-878  Abstract
    [All authors]
    277.
    Fuchs G., Voichek Y., Rabani M., Benjamin S., Gilad S., Amit I. & Oren M. (2015) Nature protocols. 10, 4, p. 605-618  Abstract
    276.
    Furth N., Bossel Ben-Moshe B. N., Pozniak Y., Porat Z., Geiger T., Domany E., Aylon Y. & Oren M. (2015) Genes and Development. 29, p. 2325-2330  Abstract

    2014

    275.
    Lasry A., Aran D., Zinger A. et al. (2014) Cytokine. 70, 1, p. 22-22  Abstract
    [All authors]
    274.
    Fuchs G., Hollander D., Voichek Y., Ast G. & Oren M. (2014) Genome Research. 24, 10, p. 1572-1583  Abstract
    273.
    Cooks T., Harris C. & Oren M. (2014) Carcinogenesis. 35, 8, p. 1680-1690  Abstract
    272.
    Golomb L., Volarevic S. & Oren M. (2014) FEBS Letters. 588, 16, p. 2571-2579  Abstract
    271.
    Fuchs G. & Oren M. (2014) Biochimica et Biophysica Acta - Gene Regulatory Mechanisms. 1839, 8, p. 694-701  Abstract
    270.
    Weilbacher A., Gutekunst M., Oren M., Aulitzky W. E. & van der Kuip d. K. H. (2014) Cell Death & Disease. 5, 7, e1318.  Abstract
    269.
    Oren M. (2014) European Journal of Cancer. 50, p. VII  Abstract
    268.
    Hoffman Y., Pilpel Y. & Oren M. (2014) Journal of Molecular Cell Biology. 6, 3, p. 192-197  Abstract
    267.
    Aylon Y., Sarver A., Tovy A., Ainbinder E. & Oren M. (2014) Cell Death and Differentiation. 21, 4, p. 624-633  Abstract
    266.
    Hoffman Y., Bublik D. R., Pilpel Y. & Oren M. (2014) Cell Death and Differentiation. 21, 2, p. 302-309  Abstract
    265.
    Shtivelman E., Davies M. A., Hwu P., Yang J., Lotem M., Oren M., Flaherty K. T. & Fisher D. E. (2014) Oncotarget. 5, 7, p. 1701-1752  Abstract
    264.
    Fuchs G., Voichek Y., Benjamin S., Gilad S., Amit I. & Oren M. (2014) GENOME BIOLOGY. 15, 5, p. R69  Abstract
    263.
    Weingarten-Gabbay S., Khan D., Liberman N., Yoffe Y., Bialik S., Das S., Oren M. & Kimchi A. (2014) Oncogene. 33, 5, p. 611-618  Abstract

    2013

    262.
    Fausti F., Di Agostino A. S., Cioce M. et al. (2013) Cell Death and Differentiation. 20, 11, p. 1498-1509  Abstract
    [All authors]
    261.
    Golomb L. & Oren M. (2013) Cell Death and Differentiation. 20, 11, p. 1442-1443  Abstract
    260.
    Pribluda A., Elyada E., Wiener Z. et al. (2013) Cancer Cell. 24, 2, p. 242-256  Abstract [All authors]
    259.
    Cooks T., Pateras I. S., Tarcic O. et al. (2013) Cancer Cell. 23, 5, p. 634-646  Abstract [All authors]
    258.
    Gutekunst M., Mueller T., Weilbacher A., Dengler M. A., Oren M., Aulitzky W. E. & van der Kuip d. K. H. (2013)  Abstract
    257.
    Hoffman Y., Dahary D., Bublik D. R., Oren M. & Pilpel Y. (2013) Bioinformatics. 29, 7, p. 894-902  Abstract
    256.
    Gutekunst M., Mueller T., Weilbacher A., Dengler M. A., Bedke J., Kruck S., Oren M., Aulitzky W. E. & Van Der Kuip H. (2013) Cancer Research. 73, 5, p. 1460-1469  Abstract
    255.
    Suzuki H., Yabuta N., Okada N., Torigata K., Aylon Y., Oren M. & Nojima H. (2013) Journal of Cell Science. 126, 19, p. 4358-4368  Abstract
    254.
    Shema E., Nikolov M., Haj-Yahya M. et al. (2013) Cell Reports. 4, 3, p. 601-608  Abstract [All authors]

    2012

    253.
    Bursać S., Brdovčak M. C., Pfannkuchen M. et al. (2012) Proceedings of the National Academy of Sciences of the United States of America. 109, 50, p. 20467-20472  Abstract [All authors]
    252.
    Hornung G., Bar-Ziv R., Rosin D., Tokuriki N., Tawfik D., Oren M. & Barkai N. (2012) Genome Research. 22, 12, p. 2409-2417  Abstract
    251.
    Haj-Yahya M., Eltarteer N., Ohayon S., Shema E., Kotler E., Oren M. & Brik A. (2012) ANGEWANDTE CHEMIE-INTERNATIONAL EDITION. 51, 46, p. 11535-11539  Abstract
    250.
    Schmid J. O., Dong M., Haubeiss S. et al. (2012) Cancer Research. 72, 22, p. 5824-5832  Abstract
    [All authors]
    249.
    Fuchs G., Shema E., Vesterman R. et al. (2012) Molecular Cell. 46, 5, p. 662-673  Abstract [All authors]
    248.
    Hornung G., Oren M. & Barkai N. (2012) Molecular Cell. 46, 3, p. 362-368  Abstract
    247.
    Bublik D. R. & Oren M. (2012) EMBO Reports. 13, 4, p. 282-283  Abstract
    246.
    Zwang Y., Oren M. & Yarden Y. (2012) Cancer Research. 72, 5, p. 1051-1054  Abstract
    245.
    Blandino G., Deppert W., Hainaut P., Levine A., Lozano G., Olivier M., Rotter V., Wiman K. & Oren M. (2012) Cell Death and Differentiation. 19, 1, p. 180-183  Abstract
    244.
    Golomb L., Bublik D. R., Wilder S., Nevo R., Kiss V., Grabusic K., Volarevic S. & Oren M. (2012) Molecular Cell. 45, 2, p. 222-232  Abstract

    2011

    243.
    Furth N. & Oren M. (2011) Cell Cycle. 10, 18, p. 3054-3055  Abstract
    242.
    Shiloh Y., Shema E., Moyal L. & Oren M. (2011) FEBS Letters. 585, 18, p. 2795-2802  Abstract
    241.
    Golomb L. & Oren M. (2011) Cancer Cell. 20, 3, p. 283-284  Abstract
    240.
    Aylon Y. & Oren M. (2011) Molecular Oncology. 5, 4, p. 315-323  Abstract
    239.
    Tarocchi M., Hannivoort R., Hoshida Y. et al. (2011) Hepatology. 54, 2, p. 522-531  Abstract
    [All authors]
    238.
    Shema E., Oren M. & Minsky N. (2011) Methods. 54, 3, p. 326-330  Abstract
    237.
    Dell'Orso S., Fontemaggi G., Stambolsky P. et al. (2011) Omics-A Journal Of Integrative Biology. 15, 5, p. 305-312  Abstract [All authors]
    236.
    Shema E., Kim J., Roeder R. G. & Oren M. (2011) Molecular Cell. 42, 4, p. 477-488  Abstract
    235.
    Zwang Y., Sas-Chen A., Drier Y. et al. (2011) Molecular Cell. 42, 4, p. 524-535  Abstract [All authors]
    234.
    Aylon Y. & Oren M. (2011) Current opinion in genetics & development. 21, 1, p. 86-92  Abstract
    233.
    Elyada E., Pribluda A., Goldstein R. E. et al. (2011) Nature. 470, 7334, p. 409-413  Abstract [All authors]
    232.
    Goldstein I., Marcel V., Olivier M., Oren M., Rotter V. & Hainaut P. (2011) Cancer Gene Therapy. 18, 1, p. 2-11  Abstract
    231.
    Gutekunst M., Oren M., Weilbacher A., Dengler M. A., Markwardt C., Thomale J., Aulitzky W. E. & van der Kuip H. (2011) PLoS ONE. 6, 4, e19198.  Abstract
    230.
    Okada N., Yabuta N., Suzuki H., Aylon Y., Oren M. & Nojima H. (2011) Journal of Cell Science. 124, 1, p. 57-67  Abstract

    2010

    229.
    Addadi Y., Moskovits N., Granot D., Lozano G., Carmi Y., Apte R. N., Neeman M. & Oren M. (2010) Cancer Research. 70, 23, p. 9650-9658  Abstract
    228.
    Aylon Y., Ofir-Rosenfeld Y., Yabuta N., Lapi E., Nojima H., Lu X. & Oren M. (2010) GENES & DEVELOPMENT. 24, 21, p. 2420-2429  Abstract
    227.
    Nili E. L., Field Y., Lubling Y., Widom J., Oren M. & Segal E. (2010) Genome Research. 20, 10, p. 1361-1368  Abstract
    226.
    Scherz-Shouval R., Weidberg H., Gonen C., Wilder S., Elazar Z. & Oren M. (2010) Proceedings of the National Academy of Sciences of the United States of America. 107, 43, p. 18511-18516  Abstract
    225.
    Shalgi R., Pilpel Y. & Oren M. (2010) Trends in Genetics. 26, 6, p. 253-259  Abstract
    224.
    Stambolsky P., Tabach Y., Fontemaggi G. et al. (2010) Cancer Cell. 17, 5, p. 523  Abstract [All authors]
    223.
    Schilling T., Kairat A., Melino G., Krammer P. H., Stremmel W., Oren M. & Müller M. (2010) Biochemical and Biophysical Research Communications. 394, 3, p. 817-823  Abstract
    222.
    Oren M. & Cooks T. (2010) Cell Cycle. 9, 6, p. 1025-1030  Abstract
    221.
    Stambolsky P., Tabach Y., Fontemaggi G. et al. (2010) Cancer Cell. 17, 3, p. 273-285  Abstract [All authors]
    220.
    Oren M. & Rotter V. (2010) Cold Spring Harbor perspectives in biology. 2, 2, p. a001107  Abstract
    219.
    Bar J., Moskovits N. & Oren M. (2010) SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY. 21, 1, p. 47-54  Abstract
    218.
    Christoffersen N. R., Shalgi R., Frankel L. B. et al. (2010) Cell Death and Differentiation. 17, 2, p. 236-245  Abstract [All authors]

    2009

    217.
    Skorta I., Oren M., Markwardt C., Gutekunst M., Aulitzky W. E. & Van Der Kuip H. (2009) Cancer Research. 69, 24, p. 9337-9345  Abstract
    216.
    Aylon Y., Yabuta N., Besserglick H., Buganim Y., Rotter V., Nojima H. & Oren M. (2009) Oncogene. 28, 50, p. 4469-4479  Abstract
    215.
    Levine A. J. & Oren M. (2009) Nature Reviews Cancer. 9, 10, p. 749-758  Abstract
    214.
    Schilling T., Schleithoff E. S., Kairat A., Melino G., Stremmel W., Oren M., Krammer P. H. & Müller M. (2009) Biochemical and Biophysical Research Communications. 387, 2, p. 399-404  Abstract
    213.
    Coupling transcriptional and post-transcriptional miRNA regulation in the control of cell fate
    Shalgi R., Brosh R., Oren M., Pilpel Y. & Rotter V. (2009) AGING-US. 1, 9, p. 762-770  Abstract
    212.
    Bar J., Feniger-Barish R., Lukashchuk N. et al. (2009) Oncogene. 28, 6, p. 933-936  Abstract [All authors]
    211.
    Pirngruber J., Shchebet A., Schreiber L. et al. (2009) EMBO Reports. 10, 8, p. 894-900  Abstract [All authors]
    210.
    Lavelin I., Beer A., Kam Z., Rotter V., Oren M., Navon A. & Geiger B. (2009) PLoS ONE. 4, 12, e8503.  Abstract

    2008

    209.
    Ofir-Rosenfeld Y., Boggs K., Michael D., Kastan M. B. & Oren M. (2008) Molecular Cell. 32, 2, p. 180-189  Abstract
    208.
    Shema E., Tirosh I., Aylon Y. et al. (2008) GENES & DEVELOPMENT. 22, 19, p. 2664-2676  Abstract [All authors]
    207.
    Finkin S., Aylon Y., Anzi S., Oren M. & Shaulian E. (2008) Oncogene. 27, 32, p. 4411-4421  Abstract
    206.
    Bossi G., Marampon F., Maor-Aloni R., Zani B., Rotter V., Oren M., Strano S., Blandino G. & Sacchi A. (2008) Cell Cycle. 7, 12, p. 1870-1879  Abstract
    205.
    Abe Y., Oda-Sato E., Tobiume K., Kawauchi K., Taya Y., Okamoto K., Oren M. & Tanaka N. (2008) Proceedings of the National Academy of Sciences of the United States of America. 105, 12, p. 4838-4843  Abstract
    204.
    Minsky N., Shema E., Field Y., Schuster M., Segal E. & Oren M. (2008) Nature Cell Biology. 10, 4, p. 483-488  Abstract
    203.
    Brosh R., Shalgi R., Liran A. et al. (2008) Molecular Systems Biology. 4, 229.  Abstract
    [All authors]

    2007

    202.
    Lantner F., Starlets D., Gore Y. et al. (2007) Blood. 110, 13, p. 4303-4311  Abstract
    [All authors]
    201.
    Raver-Shapira N. & Oren M. (2007) Cell Cycle. 6, 21, p. 2656-2661  Abstract
    200.
    Lu X., Ma O., Nguyen T. A., Jones S. N., Oren M. & Donehower L. A. (2007) Cancer Cell. 12, 4, p. 342-354  Abstract
    199.
    Reef S., Shifman O., Oren M. & Kimchi A. (2007) Oncogene. 26, 46, p. 6677-6683  Abstract
    198.
    Aylon Y. & Oren M. (2007) Cell. 130, 4, p. 597-600  Abstract
    197.
    Shalgi R., Lieber D., Oren M. & Pilpel Y. (2007) PLoS Computational Biology. 3, 7, p. 1291-1304  Abstract
    196.
    Raver-Shapira N., Marciano E., Meiri E., Spector Y., Rosenfeld N., Moskovits N., Bentwich Z. & Oren M. (2007) Molecular Cell. 26, 5, p. 731-743  Abstract
    195.
    Weisz L., Oren M. & Rotter V. (2007) Oncogene. 26, 15, p. 2202-2211  Abstract
    194.
    Weisz L., Damalas A., Liontos M. et al. (2007) Cancer Research. 67, 6, p. 2396-2401  Abstract [All authors]
    193.
    Oren M. & Bartek J. (2007) Cell. 128, 5, p. 826-828  Abstract
    192.
    Shmueli A. & Oren M. (2007) Molecular Cell. 25, 6, p. 794-796  Abstract

    2006

    191.
    Stambolsky P., Weisz L., Shats I., Klein Y. A., Goldfinger N., Oren M. & Rotter V. (2006) Cell Death and Differentiation. 13, 12, p. 2140-2149  Abstract
    190.
    Moskovits N., Kalinkovich A., Bar J., Lapidot T. & Oren M. (2006) Cancer Research. 66, 22, p. 10671-10676  Abstract
    189.
    Oren M. (2006) Ejc Supplements. 4, 12, p. 76-76  Abstract
    188.
    Aylon Y., Michael D., Shmueli A., Yabuta N., Nojima H. & Oren M. (2006) Genes and Development. 20, 19, p. 2687-2700  Abstract
    187.
    Rentsch C. A., Germann M., Wetterwald A. et al. (2006) European Urology Supplements. 5, 14, p. 790-790  Abstract
    [All authors]
    186.
    Avkin S., Sevilya Z., Toube L., Geacintov N., Chaney S., Oren M. & Livneh Z. (2006) Molecular Cell. 22, 3, p. 407-413  Abstract
    185.
    Reef S., Zalckvar E., Shifman O., Bialik S., Sabanay H., Oren M. & Kimchi A. (2006) Molecular Cell. 22, 4, p. 463-475  Abstract
    184.
    Kogan I., Goldfinger N., Milyavsky M. et al. (2006) Cancer Research. 66, 7, p. 3531-3540  Abstract
    [All authors]
    183.
    Margalit O., Amram H., Amariglio N. et al. (2006) Blood. 107, 4, p. 1599-1607  Abstract [All authors]
    182.
    Zalcenstein A., Weisz L., Stambolsky P., Bar J., Rotter V. & Oren M. (2006) Oncogene. 25, 3, p. 359-369  Abstract

    2005

    181.
    Bar J., Lukaschuk N., Zalcenstein A., Wilder S., Seger R. & Oren M. (2005) Cell Death and Differentiation. 12, 12, p. 1578-1587  Abstract
    180.
    Muller M., Schilling T., Sayan A. et al. (2005) Cell Death and Differentiation. 12, 12, p. 1564-1577  Abstract [All authors]
    179.
    Shmueli A. & Oren M. (2005) Cell. 121, 7, p. 963-965  Abstract
    178.
    Gressner O., Schilling T., Lorenz K. et al. (2005) EMBO Journal. 24, 13, p. 2458-2471  Abstract [All authors]
    177.
    Oberst A., Rossi M., Salornoni P., Pandolfi P., Oren M., Melino G. & Bernassola F. (2005) Biochemical and Biophysical Research Communications. 331, 3, p. 707-712  Abstract
    176.
    Hershko T., Chaussepied M., Oren M. & Ginsberg D. (2005) Cell Death and Differentiation. 12, 4, p. 377-383  Abstract
    175.
    Wohlbold L., van der Kuip d. K. H., Moehring A., Granot G., Oren M., Vornlocher H. & Aulitzky W. (2005) Leukemia. 19, 2, p. 290-292  Abstract
    174.
    Damalas A., Weis L., Nordgard S. et al. (2005) Breast Cancer Research. 7, p. S53-S53  Abstract
    [All authors]

    2004

    173.
    Minsky N. & Oren M. (2004) Molecular Cell. 16, 4, p. 631-639  Abstract
    172.
    Weisz L., Zalcenstein A., Stambolsky P., Cohen Y., Goldfinger N., Oren M. & Rotter V. (2004) Cancer Research. 64, 22, p. 8318-8327  Abstract
    171.
    Daniely Y., Liao G., Dixon D., Linnoila R. I., Lori A., Randell S. H., Oren M. & Jetten A. M. (2004) American Journal Of Physiology-Cell Physiology. 287, 1 56-1, p. C171-C181  Abstract
    170.
    Levina E., Oren M. & Ben-Ze'ev A. (2004) Oncogene. 23, 25, p. 4444-4453  Abstract
    169.
    Bar J., Cohen-Noyman E., Geiger B. & Oren M. (2004) Oncogene. 23, 12, p. 2128-2137  Abstract
    168.
    Fiucci G., Beaucourt S., Duflaut D. et al. (2004) Proceedings of the National Academy of Sciences of the United States of America. 101, 10, p. 3510-3515  Abstract
    [All authors]
    167.
    Wang X., Taplick J., Geva N. & Oren M. (2004) FEBS Letters. 561, 1-3, p. 195-201  Abstract
    166.
    Shmueli A. & Oren M. (2004) Molecular Cell. 13, 1, p. 4-5  Abstract

    2003

    165.
    Zalcenstein A., Stambolsky P., Weisz L., Muller M., Wallach D., Goncharov T., Krammer P., Rotter V. & Oren M. (2003) Oncogene. 22, 36, p. 5667-5676  Abstract
    164.
    Oren M. (2003) Cell Death and Differentiation. 10, 4, p. 431-442  Abstract
    163.
    Wang X., Zalcenstein A. & Oren M. (2003) Cell Death and Differentiation. 10, 4, p. 468-476  Abstract
    162.
    Ofek P., Ben-Meir D., Kariv-Inbal Z., Oren M. & Lavi S. (2003) Journal of Biological Chemistry. 278, 16, p. 14299-14305  Abstract
    161.
    Passer B., Nancy-Portebois V., Amzallag N. et al. (2003) Proceedings of the National Academy of Sciences of the United States of America. 100, 5, p. 2284-2289  Abstract [All authors]
    160.
    Michael D. & Oren M. (2003) Seminars in Cancer Biology. 13, 1, p. 49-58  Abstract
    159.
    Nuclear factor-κB protects the liver against genotoxic stress and functions independently of p53
    Lavon I., Pikarsky E., Gutkovich E., Goldberg I., Bar J., Oren M. & Ben-Neriah Y. (2003) Cancer Research. 63, 1, p. 25-30  Abstract

    2002

    158.
    Blandert G., Zalle N., Daniely Y., Taplick J., Gray M. D. & Oren M. (2002) Journal of Biological Chemistry. 277, 52, p. 50934-50940  Abstract
    157.
    Oren M., DAMALAS A., GOTTLIEB T. et al. (2002) Annals of the New York Academy of Sciences. 973, 1, p. 374-383  Abstract
    [All authors]
    156.
    Balass M., Kalef E., Maya R., Wilder S., Oren M. & Katchalski-Katzir E. (2002) Peptides. 23, 10, p. 1719-1725  Abstract
    155.
    Shtutman M., Zhurinsky J., Oren M., Levina E. & Ben-Ze'ev A. (2002) Cancer Research. 62, 20, p. 5947-5954  Abstract
    154.
    Goldberg Z., Vogt Sionov S. R., Berger M., Zwang Y., Perets R., Van Etten E. R., Oren M., Taya Y. & Haupt Y. (2002) EMBO Journal. 21, 14, p. 3715-3727  Abstract
    153.
    Strano S., Fontemaggi G., Costanzo A. et al. (2002) Journal of Biological Chemistry. 277, 21, p. 18817-18826  Abstract [All authors]
    152.
    Wang X., Michael D., De Murcia G. & Oren M. (2002) Journal of Biological Chemistry. 277, 18, p. 15697-15702  Abstract
    151.
    Folberg-Blum A., Sapir A., Shilo B. & Oren M. (2002) Oncogene. 21, 15, p. 2413-2417  Abstract
    150.
    Michael D. & Oren M. (2002) Current opinion in genetics & development. 12, 1, p. 53-59  Abstract
    149.
    Gottlieb T., Leal J., Seger R., Taya Y. & Oren M. (2002) Oncogene. 21, 8, p. 1299-1303  Abstract
    148.
    Courtois S., Verhaegh G., North S., Luciani M., Lassus P., Hibner U., Oren M. & Hainaut P. (2002) Oncogene. 21, 44, p. 6722-6728  Abstract

    2001

    147.
    Susini L., Passer B., Amzallag-Elbaz N. et al. (2001) Proceedings of the National Academy of Sciences of the United States of America. 98, 26, p. 15067-15072  Abstract
    [All authors]
    146.
    Requirement for Mdm2 in the survival effects of Bcr-Abl and interleukin 3 in hematopoietic cells
    Goetz A., van der Kuip d. K. H., Maya R., Oren M. & Aulitzky W. (2001) Cancer Research. 61, 20, p. 7635-7641  Abstract
    145.
    Damalas A., Kahan S., Shtutman M., Ben-Ze'ev A. & Oren M. (2001) EMBO Journal. 20, 17, p. 4912-4922  Abstract
    144.
    Maya R., Balass M., Kim S. et al. (2001) GENES & DEVELOPMENT. 15, 9, p. 1067-1077  Abstract [All authors]
    143.
    Strano S., Munarriz E., Rossi M. et al. (2001) Journal of Biological Chemistry. 276, 18, p. 15164-15173  Abstract [All authors]
    142.
    Oren M. (2001) Experimental Cell Research. 264, 1, p. 1  Abstract
    141.
    The p53 saga: the good, the bad, and the dead.
    Oren M. (2001) Harvey lectures. 97, p. 57-82  Abstract
    140.
    Sadot E., Geiger B., Oren M. & Ben-Ze'ev A. (2001) Molecular and Cellular Biology. 21, 20, p. 6768-6781  Abstract

    2000

    139.
    Reinstein E., Scheffner M., Oren M., Ciechanover A. & Schwartz A. (2000) Oncogene. 19, 51, p. 5944-5950  Abstract
    138.
    Bar-Or R., Maya R., Segel L., Alon U., Levine A. & Oren M. (2000) Proceedings of the National Academy of Sciences of the United States of America. 97, 21, p. 11250-11255  Abstract
    137.
    Ries S., Biederer C., Woods D., Shifman O., Shirasawa S., Sasazuki T., McMahon M., Oren M. & McCormick F. (2000) Cell. 103, 2, p. 321-330  Abstract
    136.
    Strano S., Munarriz E., Rossi M. et al. (2000) Journal of Biological Chemistry. 275, 38, p. 29503-29512  Abstract [All authors]
    135.
    Maya R. & Oren M. (2000) Oncogene. 19, 28, p. 3213-3215  Abstract
    134.
    Amson R., Lassalle J., Halley H. et al. (2000) Proceedings of the National Academy of Sciences of the United States of America. 97, 10, p. 5346-5350  Abstract
    [All authors]
    133.
    de Rozieres R. S., Maya R., Oren M. & Lozano G. (2000) Oncogene. 19, 13, p. 1691-1697  Abstract
    132.
    Blander G., Zalle N., Leal J., Bar-Or R., Yu C. & Oren M. (2000) FASEB Journal. 14, 14, p. 2138-2140  Abstract

    1999

    131.
    Khosravi R., Maya R., Gottlieb T., Oren M., Shiloh Y. & Shkedy D. (1999) Proceedings of the National Academy of Sciences of the United States of America. 96, 26, p. 14973-14977  Abstract
    130.
    Oren M. (1999) Journal of Biological Chemistry. 274, 51, p. 36031-36034  Abstract
    129.
    Blander G., Kipnis J., Leal J., Yu C., Schellenberg G. & Oren M. (1999) Journal of Biological Chemistry. 274, 41, p. 29463-29469  Abstract
    128.
    Elkeles A. & Oren M. (1999) Molecular Medicine Today. 5, 8, p. 334-335  Abstract
    127.
    Roperch J., Lethrone F., Prieur S. et al. (1999) Proceedings of the National Academy of Sciences of the United States of America. 96, 14, p. 8070-8073  Abstract
    [All authors]
    126.
    Agami R., Blandino G., Oren M. & Shaul Y. (1999) Nature. 399, 6738, p. 809-812  Abstract
    125.
    Damalas A., Ben-Ze'ev A., Simcha I., Shtutman N., Leal J., Zhurinsky J., Geiger B. & Oren M. (1999) EMBO Journal. 18, 11, p. 3054-3063  Abstract
    124.
    Hot papers - Cancer research - Mdm2 promotes the rapid degradation of p53 by Y. Haupt, R. Maya, A. Kazaz, M. Oren and Regulation of p53 stability by Mdm2 by M.H.G. Kubbutat, S.N. Jones, K.H. Vousden - Comments
    Oren M. & Vousden K. (1999) Scientist. 13, 12, p. 11-11  Abstract
    123.
    Unger T., Sionov R., Moallem E., Yee C., Howley P., Oren M. & Haupt Y. (1999) Oncogene. 18, 21, p. 3205-3212  Abstract
    122.
    MDM2 suppresses p73 function without promoting p73 degradation
    Zeng X., Chen L., Jost C. et al. (1999) Molecular and Cellular Biology. 19, 5, p. 3257-3266  Abstract [All authors]
    121.
    Unger T., Juven-Gershon T., Moallem E., Berger M., Sionov R., Lozano G., Oren M. & Haupt Y. (1999) EMBO Journal. 18, 7, p. 1805-1814  Abstract
    120.
    Elkeles A., Juven-Gershon T., Israeli D., Wilder S., Zalcenstein A. & Oren M. (1999) Molecular and Cellular Biology. 19, 4, p. 2594-2600  Abstract
    119.
    Sionov R., Moallem E., Berger M., Kazaz A., Gerlitz O., Ben-Neriah Y., Oren M. & Haupt Y. (1999) Journal of Biological Chemistry. 274, 13, p. 8371-8374  Abstract
    118.
    Juven-Gershon T. & Oren M. (1999) Molecular Medicine. 5, 2, p. 71-83  Abstract
    117.
    Blandino G., Levine A. & Oren M. (1999) Oncogene. 18, 2, p. 477-485  Abstract
    116.
    Oren M. & Rotter V. (1999) Cellular and Molecular Life Sciences. 55, 1, p. 9-11  Abstract

    1998

    115.
    Muller M., Wilder S., Bannasch D. et al. (1998) Journal of Experimental Medicine. 188, 11, p. 2033-2045  Abstract [All authors]
    114.
    Wang Y., Blandino G., Oren M. & Givol D. (1998) Oncogene. 17, 15, p. 1923-1930  Abstract
    113.
    Gottlieb E. & Oren M. (1998) EMBO Journal. 17, 13, p. 3587-3596  Abstract
    112.
    Roperch J., Alvaro V., Prieur S. et al. (1998) Nature Medicine. 4, 7, p. 835-838  Abstract
    [All authors]
    111.
    Juven-Gershon T., Shifman O., Unger T., Elkeles A., Haupt Y. & Oren M. (1998) Molecular and Cellular Biology. 18, 7, p. 3974-3982  Abstract
    110.
    Yardley G., Zauberman A., Oren M. & Jackson P. (1998) FEBS Letters. 430, 3, p. 171-175  Abstract
    109.
    Ori A., Zauberman A., Doitsh G., Paran N., Oren M. & Shaul Y. (1998) EMBO Journal. 17, 2, p. 544-553  Abstract
    108.
    Oren M. (1998) Nature. 391, 6664, p. 233-234  Abstract
    107.
    Hosokawa K., Aharoni D., Dantes A. et al. (1998) Endocrinology. 139, 11, p. 4688-4700  Abstract
    [All authors]

    1997

    106.
    Gottlieb T. M. & Oren M. (1997) Seminars in Cancer Biology. 8, 5, p. 359-368  Abstract
    105.
    Israeli D., Tessler E., Haupt Y., Elkeles A., Wilder S., Amson R., Telerman A. & Oren M. (1997) EMBO Journal. 16, 14, p. 4384-4392  Abstract
    104.
    Haupt Y., Maya R., Kazaz A. & Oren M. (1997) Nature. 387, 6630, p. 296-299  Abstract
    103.
    Ruaro E., Collavin L., DelSal G., Haffner R., Oren M., Levine A. & Schneider C. (1997) Proceedings of the National Academy of Sciences of the United States of America. 94, 9, p. 4675-4680  Abstract
    102.
    Gottlieb E., Haffner R., King A., Asher G., Gruss P., Lonai P. & Oren M. (1997) EMBO Journal. 16, 6, p. 1381-1390  Abstract
    101.
    Hansen R. & Oren M. (1997) Current opinion in genetics & development. 7, 1, p. 46-51  Abstract
    100.
    Friedman S., Shaulian E., Littlewood T., Resnitzky D. & Oren M. (1997) Oncogene. 15, 1, p. 63-70  Abstract
    98.
    Zauberman A., Oren M. & Zipori D. (1997) Oncogene. 15, 14, p. 1705-1711  Abstract
    97.
    Shaulian E., Resnitzky D., Shifman O., Blandino G., Amsterdam A., Yayon A. & Oren M. (1997) Oncogene. 15, 22, p. 2717-2725  Abstract

    1996

    96.
    p53-mediated apoptosis: mechanisms and regulation.
    Haupt Y. & Oren M. (1996) Behring Institute Mitteilungen. 97, p. 32-59  Abstract
    95.
    Nemani M., LinaresCruz G., BruzzoniGiovanelli H. et al. (1996) Proceedings of the National Academy of Sciences of the United States of America. 93, 17, p. 9039-9042  Abstract
    [All authors]
    94.
    Bowman T., Symonds H., Gu L., Yin C., Oren M. & Van Dyke T. (1996) GENES & DEVELOPMENT. 10, 7, p. 826-835  Abstract
    93.
    Haupt Y., Barak Y. & Oren M. (1996) EMBO Journal. 15, 7, p. 1596-1606  Abstract
    92.
    Relationship of sequence-specific transactivation and p53-regulated apoptosis in interleukin 3-dependent hematopoietic cells
    Gottlieb E., Lindner S. & Oren M. (1996) Cell Growth and Differentiation. 7, 3, p. 301-310  Abstract
    91.
    Rowan S., Ludwig R., Haupt Y., Bates S., Lu X., Oren M. & Vousden K. (1996) EMBO Journal. 15, 4, p. 827-838  Abstract
    90.
    Tanaka N., Ishihara M., Lamphier M. et al. (1996) Nature. 382, 6594, p. 816-818  Abstract
    [All authors]
    89.
    Neu differentiation factor (Heregulin) activates a p53-dependent pathway in cancer cells
    Bacus S., Yarden Y., Oren M. et al. (1996) Oncogene. 12, 12, p. 2535-2547  Abstract
    [All authors]
    88.
    Eizenberg O., FaberElman A., Gottlieb E., Oren M., Rotter V. & Schwartz M. (1996) Molecular and Cellular Biology. 16, 9, p. 5178-5185  Abstract
    87.
    p53-Mediated apoptosis - Regulatory and mechanistic aspects
    Haupt Y., Rowan S., Shaulian E., Gottlieb E., YonishRouach E., Vousden K. & Oren M. (1996) Cancer Genes: Functional Aspects. 7, p. 83-101  Abstract
    86.
    Oren M. & Prives C. (1996) Biochimica Et Biophysica Acta-Reviews On Cancer. 1288, 3, p. R13-R19  Abstract
    85.
    Friedlander P., Haupt Y., Prives C. & Oren M. (1996) Molecular and Cellular Biology. 16, 9, p. 4961-4971  Abstract
    84.
    Gottlieb T. M. & Oren M. (1996) Biochimica Et Biophysica Acta-Reviews On Cancer. 1287, 2-3, p. 77-102  Abstract

    1995

    83.
    HIEBERT S., PACKHAM G., STROM D., HAFFNER R., Oren M., ZAMBETTI G. & CLEVELAND J. (1995) Molecular and Cellular Biology. 15, 12, p. 6864-6874  Abstract
    82.
    Cancer: The translation of advances in basic science to human therapy. 22-27 July, 1995 - La fondation des Treilles, Tourtour, France - Discussion
    Harlow E., Tlsty T., Courtneidge S. et al. (1995) Comptes Rendus De L Academie Des Sciences Serie Iii-Sciences De La Vie-Life Sciences. 318, 11, p. 1173-1179  Abstract
    [All authors]
    81.
    Malcomson R. D., Oren M., Wyllie A. H. & Harrison D. J. (1995) British Journal of Cancer. 72, 4, p. 952-957  Abstract
    80.
    HAUPT Y., ROWAN S., SHAULIAN E., VOUSDEN K. & Oren M. (1995) GENES & DEVELOPMENT. 9, 17, p. 2170-2183  Abstract
    79.
    Zauberman A., FLUSBERG D., HAUPT Y., Barak Y. & Oren M. (1995) Nucleic Acids Research. 23, 14, p. 2584-2592  Abstract
    78.
    IDENTIFICATION OF P53 TARGET GENES THROUGH IMMUNE SELECTION OF GENOMIC DNA - THE CYCLIN-G GENE CONTAINS 2 DISTINCT P53 BINDING-SITES
    Zauberman A., LUPO A. & Oren M. (1995) Oncogene. 10, 12, p. 2361-2366  Abstract
    77.
    AHARONI D., Dantes A., Oren M. & Amsterdam A. (1995) Experimental Cell Research. 218, 1, p. 271-282  Abstract
    76.
    KERENTAL I., SUH B., Dantes A., LINDNER S., Oren M. & Amsterdam A. (1995) Experimental Cell Research. 218, 1, p. 283-295  Abstract
    75.
    P53-MEDIATED APOPTOSIS IN HELA-CELLS CAN BE OVERCOME BY EXCESS PRB
    HAUPT Y., ROWAN S. & Oren M. (1995) Oncogene. 10, 8, p. 1563-1571  Abstract
    74.
    EIZENBERG O., FABER-ELMAN A., GOTTLIEB E., Oren M., Rotter V. & Schwartz M. (1995) EMBO Journal. 14, 6, p. 1136-1144  Abstract
    73.
    Non-syntenic amplification of MDM2 and MYCN in human neuroblastoma
    Corvi R., Savelyeva L., Breit S., Wenzel A., Handgretinger R., Barak J., Oren M., Amler L. & Schwab M. (1995) Oncogene. 10, 6, p. 1081-1086  Abstract
    72.
    TRANSCRIPTIONAL REPRESSION BY THE C-TERMINAL DOMAIN OF P53
    SHAULIAN E., HAVIV I., Shaul Y. & Oren M. (1995) Oncogene. 10, 4, p. 671-680  Abstract
    71.
    Haffner R. & Oren M. (1995) Current Opinion in Genetics and Development. 5, 1, p. 84-90  Abstract
    70.
    STUART E., HAFFNER R., Oren M. & GRUSS P. (1995) EMBO Journal. 14, 22, p. 5638-5645  Abstract

    1994

    69.
    Degradation of the tumor suppressor protein p53 by the ubiquitin-mediated proteolytic system requires a novel species of ubiquitin-carrier protein, E2
    CIECHANOVER A., SHKEDY D., Oren M. & BERCOVICH B. (1994) Journal of Biological Chemistry. 269, 13, p. 9582-9589  Abstract
    68.
    GOTTLIEB E., HAFFNER R., VON RUDEN T., WAGNER E. & Oren M. (1994) EMBO Journal. 13, 6, p. 1368-1374  Abstract
    67.
    Relationship of p53 to the control of apoptotic cell death
    Oren M. (1994) Seminars in Cancer Biology. 5, 3, p. 221-227  Abstract
    66.
    Barak Y., GOTTLIEB E., JUVENGERSHON T. & Oren M. (1994) GENES & DEVELOPMENT. 8, 15, p. 1739-1749  Abstract
    65.
    Barak Y., LUPO A., Zauberman A., JUVEN T., ALONIGRINSTEIN R., GOTTLIEB E., Rotter V. & Oren M. (1994) Cold Spring Harbor Symposia on Quantitative Biology. 59, p. 225-235  Abstract
    64.
    WILD-TYPE P(53) ACTIVITY CONTRIBUTES TO DEPENDENCE ON HEMATOPOIETIC SURVIVAL FACTORS
    GOTTLIEB E., HAFFNER R., YONISHROUACH E., VONRUDEN T., WAGNER E. & Oren M. (1994) Apoptosis. 5, p. 31-45  Abstract

    1993

    63.
    Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene
    JUVEN T., Barak Y., Zauberman A., GEORGE D. & Oren M. (1993) Oncogene. 8, 12, p. 3411-3416  Abstract
    62.
    Levy N., YONISHROUACH E., Oren M. & Kimchi A. (1993) Molecular and Cellular Biology. 13, 12, p. 7942-7952  Abstract
    61.
    Telerman A., TUYNDER M., DUPRESSOIR T., ROBAYE B., SIGAUX F., SHAULIAN E., Oren M., ROMMELAERE J. & AMSON R. (1993) Proceedings of the National Academy of Sciences of the United States of America. 90, 18, p. 8702-8706  Abstract
    60.
    Zauberman A., Barak Y., RAGIMOV N., Levy N. & Oren M. (1993) EMBO Journal. 12, 7, p. 2799-2808  Abstract
    59.
    SHAULIAN E., Zauberman A., MILNER J., DAVIES E. & Oren M. (1993) EMBO Journal. 12, 7, p. 2789-2797  Abstract
    58.
    ALONI, YOSEF - (1936-1993) - OBITUARY
    Oren M. (1993) Oncogene. 8, 6, p. 1405-1405  Abstract
    57.
    Wild-type but not mutant p53 can repress transcription initiation in vitro by interfering with the binding of basal transcription factors to the TATA motif
    RAGIMOV N., KRAUSKOPF A., NAVOT N., Rotter V., Oren M. & ALONI Y. (1993) Oncogene. 8, 5, p. 1183-1193  Abstract
    56.
    p53-mediated cell death: Relationship to cell cycle control
    YONISHROUACH E., GRUNWALD D., Wilder S., Kimchi A., MAY E., LAWRENCE J., MAY P. & Oren M. (1993) Molecular and Cellular Biology. 13, 3, p. 1415-1423  Abstract
    55.
    Barak Y., JUVEN T., HAFFNER R. & Oren M. (1993) EMBO Journal. 12, 2, p. 461-468  Abstract
    54.
    MECHANISMS OF ACTION OF P53
    BARAK Y., GINSBERG D., MICHAEL D., RAGIMOV N., SHAULIAN E., YONISHROUACH E., ZAUBERMAN A., ALONI Y. & OREN M. (1993) PHARMACOLOGY OF CELL DIFFERENTIATION. Rifkind RA.(eds.). p. 129-141 (trueINTERNATIONAL CONGRESS SERIES).  Abstract
    53.
    Yonish-Rouach E., Ginsberg D. & Oren M. (1993) Programmed Cell Death. p. 187-201  Abstract

    1992

    52.
    Identification of a minimal transforming domain of p53: Negative dominance through abrogation of sequence-specific DNA binding
    SHAULIAN E., Zauberman A., GINSBERG D. & Oren M. (1992) Molecular and Cellular Biology. 12, 12, p. 5581-5592  Abstract
    51.
    The gene for the rat heat-shock cognate, hsc70, can suppress oncogene-mediated transformation.
    Yehiely F. & Oren M. (1992) Molecular Cancer Research. 3, 11, p. 803-809  Abstract
    50.
    p53: The ultimate tumor suppressor gene?
    Oren M. (1992) FASEB Journal. 6, 13, p. 3169-3176  Abstract
    49.
    Oren M. (1992) Cancer and Metastasis Reviews. 11, 2, p. 141-148  Abstract
    48.
    Yaacov B. & Oren M. (1992) EMBO Journal. 11, 6, p. 2115-2121  Abstract

    1991

    47.
    EIZENBERG O. & Oren M. (1991) Biochimica et Biophysica Acta - Gene Structure and Expression. 1129, 1, p. 34-42  Abstract
    46.
    Frequent p53 mutations in chemically induced murine fibrosarcoma
    Halevy O., RODEL J., Peled A. & Oren M. (1991) Oncogene. 6, 9, p. 1593-1600  Abstract
    45.
    Michael D., YEHIELY F., GOTTLIEB E. & Oren M. (1991) Journal of Virology. 65, 8, p. 4160-4168  Abstract
    44.
    Transfected mouse c-jun can inhibit transformation of primary rat embryo fibroblasts
    GINSBERG D., HIRAI S., PINHASIKIMHI O., Yaniv M. & Oren M. (1991) Oncogene. 6, 4, p. 669-672  Abstract
    43.
    Wild-type p53 can down-modulate the activity of various promoters
    GINSBERG D., MECHTA F., Yaniv M. & Oren M. (1991) Proceedings of the National Academy of Sciences of the United States of America. 88, 22, p. 9979-9983  Abstract
    42.
    Ginsberg D., Michael D. & Oren M. (1991) Molecular and Cellular Biology. 11, 1, p. 582-585  Abstract
    41.
    MICHALOVITZ D., Halevy O. & Oren M. (1991) Journal of Cellular Biochemistry. 45, 1, p. 22-29  Abstract
    40.
    Yonish-Rouach E., Resnftzky D., Lotem J., Sachs L., Kimchi A. & Oren M. (1991) Nature. 352, 6333, p. 345-347  Abstract

    1990

    39.
    Protein-binding elements in the promoter region of the mouse p53 gene
    GINSBERG D., Oren M., Yaniv M. & PIETTE J. (1990) Oncogene. 5, 9, p. 1285-1290  Abstract
    38.
    MICHALOVITZ D., Halevy O. & Oren M. (1990) Cell. 62, 4, p. 671-680  Abstract
    37.
    Eliyahu D., Michael D. Y., Eliyahu S., Pinchas-Kimhi O. & Oren M. (1990) Oncogenes in Cancer Diagnosis. Bartram CR., Munk K. & Schwab M.(eds.). p. 125-134  Abstract
    36.
    Halevy O., MICHALOVITZ D. & Oren M. (1990) Science. 250, 4977, p. 113-116  Abstract
    35.
    Regulation of the level of the oncoprotein p53 in non-transformed and transformed cells
    Reihsaus E., Kohler M., Kraiss S., Oren M. & Montenarh M. (1990) Oncogene. 5, 1, p. 137-145  Abstract

    1989

    34.
    Eliyahu D., MICHALOVITZ D., ELIYAHU S., PINHASIKIMHI O. & Oren M. (1989) Proceedings of the National Academy of Sciences of the United States of America. 86, 22, p. 8763-8767  Abstract
    32.
    Michalovitz D., Amsterdam A. & Oren M. (1989) Current Topics in Microbiology and Immunology. 144, p. 63-75  Abstract

    1988

    31.
    METH-A FIBRO-SARCOMA CELLS EXPRESS 2 TRANSFORMING MUTANT P53 SPECIES
    Eliyahu D., Goldfinger N., PINHASIKIMHI O., SHAULSKY G., SKURNIK Y., ARAI N., Rotter V. & Oren M. (1988) Oncogene. 3, 3, p. 313-321  Abstract
    30.
    Finlay C. A., Hinds P. W., Tan T. H., Eliyahu D., Oren M. & Levine A. J. (1988) Molecular and Cellular Biology. 8, 2, p. 531-539  Abstract
    29.
    Complex Formation Between the p53 Cellular Tumor Antigen and Nuclear Heat Shock Proteins
    Michalovitz (Michael) D., Pinhasi-Kimchi O., Eliyahu D., Ben-Ze'ev A. & Oren M. (1988) Cellular and Molecular Biology of Tumors and Potential Application. Liss A. R., Minna J. & Kuehl WM.(eds.). Vol. 56. p. 247-259 (trueUCLA Symposia on Molecular & Cellular Biology).  Abstract
    28.
    Kraiss S., Quaiser A., Oren M. & Montenarh M. (1988) Journal of Virology. 62, 12, p. 4737-4744  Abstract
    27.
    Amsterdam A., Zauberman A., Meir G., PINHASIKIMHI O., SUH B. & Oren M. (1988) Proceedings of the National Academy of Sciences of the United States of America. 85, 20, p. 7582-7586  Abstract

    1987

    26.
    Inhibition of cell growth mediated by plasmids encoding p53 anti-sense
    SHOHAT O., Greenberg M., REISMAN D., Oren M. & Rotter V. (1987) Oncogene. 1, 3, p. 277-283  Abstract
    25.
    Michalovitz D., Fischer-Fantuzzi L., Vesco C., Pipas J. M. & Oren M. (1987) Journal of Virology. 61, 8, p. 2648-2654  Abstract

    1986

    24.
    Michalovitz D., Eliyahu D. & Oren M. (1986) Molecular and Cellular Biology. 6, 10, p. 3531-3536  Abstract
    23.
    PINHASIKIMHI O., MICHALOVITZ D., Ben-Ze'ev A. & Oren M. (1986) Nature. 320, 6058, p. 182-185  Abstract
    22.
    KACZMAREK L., Oren M. & BASERGA R. (1986) Experimental Cell Research. 162, 1, p. 268-272  Abstract
    21.
    MOAV B., HOROWITZ M., COHEN J., RECHAVI G., Eliyahu E., Oren M. & Givol D. (1986) Gene. 48, 3-Feb, p. 297-300  Abstract

    1985

    20.
    BIENZ-TADMOR B., ZAKUT-HOURI R., LIBRESCO S., Givol D. & Oren M. (1985) The EMBO Journal. 4, 12, p. 3209-3213  Abstract
    19.
    Oren M. (1985) Biochimica et Biophysica Acta - Reviews on Cancer. 823, 1, p. 67-78  Abstract
    18.
    Eliyahu D., Michalovitz D. & Oren M. (1985) Nature. 316, 6024, p. 158-160  Abstract
    17.
    ZAKUT-HOURI R., BIENZ-TADMOR B., Givol D. & Oren M. (1985) The EMBO Journal. 4, 5, p. 1251-1255  Abstract
    16.
    ROGEL A., Popliker M., WEBB C. & Oren M. (1985) Molecular and Cellular Biology. 5, 10, p. 2851-2855  Abstract
    15.
    Le Beau M. M., Westbrook C. A., Diaz M. O., Rowley J. D. & Oren M. (1985) Nature. 316, 6031, p. 826-828  Abstract

    1984

    14.
    Wolf D., Admon S., Oren M. & Rotter V. (1984) Molecular and Cellular Biology. 4, 3, p. 552-558  Abstract
    13.
    Eliyahu D., Raz A., GRUSS P., Givol D. & Oren M. (1984) Nature. 312, 5995, p. 646-649  Abstract
    12.
    CZOSNEK H., BIENZ B., Givol D., ZAKUTHOURI R., PRAVTCHEVA D., RUDDLE F. & Oren M. (1984) Molecular and Cellular Biology. 4, 8, p. 1638-1640  Abstract
    11.
    Analysis of the gene coding for the murine cellular tumour antigen p53.
    Bienz B., Zakut-Houri R., Givol D. & Oren M. (1984) The EMBO Journal. 3, 9, p. 2179-2183  Abstract
    10.
    Pinhasi O. & Oren M. (1984) Molecular and Cellular Biology. 4, 10, p. 2180-2186  Abstract

    1983

    9.
    Oren M., BIENZ B., Givol D., RECHAVI G. & ZAKUT R. (1983) The EMBO Journal. 2, 10, p. 1633-1639  Abstract
    8.
    Zakut-Houri R., Oren M., Bienz B., Lavie V., Hazum S. & Givol D. (1983) Nature. 306, 5943, p. 594-597  Abstract
    7.
    Oren M. & Levine A. J. (1983) Proceedings Of The National Academy Of Sciences Of The United States Of America-Biological Sciences. 80, 1 I, p. 56-59  Abstract

    1982

    6.
    GIDONI D., SCHELLER A., BARNET B., HANTZOPOULOS P., Oren M. & PRIVES C. (1982) Unknown Journal. 42, 2, p. 456-466  Abstract

    1980

    5.
    Oren M., Winocour E. & PRIVES C. (1980) Proceedings Of The National Academy Of Sciences Of The United States Of America-Biological Sciences. 77, 1, p. 220-224  Abstract

    1979

    4.
    DNA-BINDING AND SEDIMENTATION PROPERTIES OF SV40 T-ANTIGENS SYNTHESIZED INVIVO AND INVITRO
    PRIVES C., BECK Y., GIDONI D., Oren M. & SHURE H. (1979) Cold Spring Harbor Symposia on Quantitative Biology. 44, p. 123-130  Abstract

    1978

    3.
    Oren M., Lavi S. & Winocour E. (1978) Virology. 85, 2, p. 404-421  Abstract

    1977

    2.
    Gluzman Y., Davison J., Oren M. & Winocour E. (1977) Journal of Virology. 22, 2, p. 256-266  Abstract

    1976

    1.
    Oren M., Kuff E. L. & Winocour E. (1976) Virology. 73, 2, p. 419-430  Abstract